Zsírmáj (MASLD/MASH): nyitott vizsgálatok itt: Dánia
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozResearch participation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Where
- Copenhagen Nv, Hvidovre
- Age
- 18 év and over
- People
- 205 worldwide
- Run by
- Akero Therapeutics Inc.
See details and how to join2024-512895-36-00EU 2024-512895-36-00Regiszter frissítve: 2026-10-23
3. fázisToborozTrial-stage medicine
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Hvidovre
- Age
- 18 év to 80 év
- People
- 2150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314Regiszter frissítve: 2026-10-13
No phaseToborozResearch participation
Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
- Where
- Herlev
- Age
- 34 év to 49 év
- People
- 300
- Run by
- Steno Diabetes Center Copenhagen
See details and how to joinNCT05890365Regiszter frissítve: 2026-06-11
No phaseToborozResearch participation
Identification of Liver Fibrosis Biomarkers
- Where
- Copenhagen
- Age
- 18 év to 75 év
- People
- 575 worldwide
- Run by
- Roche Diagnostics GmbH
See details and how to joinNCT06819917Regiszter frissítve: 2026-05-27
No phaseToborozResearch participation
Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
- Where
- Aarhus, Herlev
- Age
- 35 év to 40 év
- People
- 8
- Run by
- Steno Diabetes Center Copenhagen
See details and how to joinNCT05842850Regiszter frissítve: 2026-05-04
No phaseToborozResearch participation
Glucagon Resistance in Patients With MASLD and T2DM
- Where
- Aarhus
- Age
- 30 év to 70 év
- People
- 24
- Run by
- University of Aarhus
See details and how to joinNCT07246421Regiszter frissítve: 2026-02-04
No phaseToborozResearch participation
Prognostic Significance of Fatty Liver Disease in Bariatric Patients
- Where
- Esbjerg
- Age
- 18 év and over
- People
- 1200
- Run by
- Esbjerg Hospital - University Hospital of Southern Denmark
See details and how to joinNCT03535142Regiszter frissítve: 2025-03-05
No phaseToborozResearch participation
Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
- Where
- Odense
- Age
- 30 év to 75 év
- People
- 6500
- Run by
- Maja Thiele
See details and how to joinNCT03308916Regiszter frissítve: 2022-09-01
No phaseToborozResearch participation
An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
- Where
- Hvidovre
- Age
- 18 év and over
- People
- 335
- Run by
- University of Copenhagen
See details and how to joinNCT05335603Regiszter frissítve: 2022-04-19
Minden vizsgálat (Zsírmáj (MASLD/MASH)) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.